Calamos Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.11M | Hold |
45,478
| – | – | 0.01% | 589 |
|
|
2025
Q4 | $4.09M | Sell |
45,478
-1,846
| -4% | -$175K | 0.02% | 557 |
|
|
2025
Q3 | $4.66M | Sell |
47,324
-83,000
| -64% | -$8.22M | 0.02% | 547 |
|
|
2025
Q2 | $11.9M | Sell |
130,324
-30,000
| -19% | -$2.9M | 0.05% | 369 |
|
|
2025
Q1 | $18.1M | Sell |
160,324
-118,465
| -42% | -$12.7M | 0.08% | 269 |
|
|
2024
Q4 | $29.4M | Buy |
278,789
+610
| +0.2% | +$65.5K | 0.12% | 186 |
|
|
2024
Q3 | $30M | Buy |
278,179
+253
| +0.1% | +$27.6K | 0.13% | 195 |
|
|
2024
Q2 | $30.2M | Sell |
277,926
-61,907
| -18% | -$7.3M | 0.13% | 179 |
|
|
2024
Q1 | $44.9M | Buy |
339,833
+13,204
| +4% | +$1.65M | 0.21% | 119 |
|
|
2023
Q4 | $39.8M | Buy |
326,629
+30,908
| +10% | +$3.45M | 0.19% | 138 |
|
|
2023
Q3 | $33.2M | Buy |
295,721
+130,027
| +78% | +$16.5M | 0.17% | 162 |
|
|
2023
Q2 | $24.1M | Buy |
165,694
+46,408
| +39% | +$6.31M | 0.12% | 215 |
|
|
2023
Q1 | $15.4M | Buy |
119,286
+61,224
| +105% | +$7.69M | 0.08% | 324 |
|
|
2022
Q4 | $7.4M | Sell |
58,062
-10,266
| -15% | -$1.19M | 0.03% | 561 |
|
|
2022
Q3 | $7.14M | Hold |
68,328
| – | – | 0.03% | 586 |
|
|
2022
Q2 | $7.18M | Buy |
68,328
+1,840
| +3% | +$218K | 0.03% | 598 |
|
|
2022
Q1 | $8.5M | Buy |
66,488
+7,133
| +12% | +$860K | 0.03% | 563 |
|
|
2021
Q4 | $7.32M | Buy |
59,355
+2,298
| +4% | +$301K | 0.03% | 600 |
|
|
2021
Q3 | $8.11M | Buy |
57,057
+5,035
| +10% | +$741K | 0.04% | 485 |
|
|
2021
Q2 | $8.12M | Buy |
52,022
+11,832
| +29% | +$1.92M | 0.04% | 460 |
|
|
2021
Q1 | $6.25M | Buy |
40,190
+1,243
| +3% | +$193K | 0.03% | 474 |
|
|
2020
Q4 | $5.83M | Sell |
38,947
-1,688
| -4% | -$238K | 0.03% | 465 |
|
|
2020
Q3 | $5.37M | Sell |
40,635
-3,565
| -8% | -$466K | 0.03% | 445 |
|
|
2020
Q2 | $5.12M | Sell |
44,200
-2,829
| -6% | -$326K | 0.04% | 444 |
|
|
2020
Q1 | $4.62M | Sell |
47,029
-3,788
| -7% | -$497K | 0.04% | 412 |
|
|
2019
Q4 | $7.38M | Sell |
50,817
-847
| -2% | -$117K | 0.04% | 430 |
|
|
2019
Q3 | $6.88M | Buy |
51,664
+4,481
| +9% | +$579K | 0.04% | 438 |
|
|
2019
Q2 | $5.39M | Buy |
47,183
+2,334
| +5% | +$273K | 0.03% | 505 |
|
|
2019
Q1 | $5.56M | Buy |
44,849
+425
| +1% | +$48.3K | 0.03% | 437 |
|
|
2018
Q4 | $4.47M | Buy |
44,424
+6,649
| +18% | +$748K | 0.03% | 468 |
|
|
2018
Q3 | $4.82M | Buy |
37,775
+2,391
| +7% | +$284K | 0.03% | 471 |
|
|
2018
Q2 | $3.83M | Buy |
35,384
+4,240
| +14% | +$461K | 0.02% | 500 |
|
|
2018
Q1 | $3.3M | Buy |
31,144
+1,470
| +5% | +$171K | 0.02% | 502 |
|
|
2017
Q4 | $3.48M | Sell |
29,674
-630
| -2% | -$71.2K | 0.02% | 470 |
|
|
2017
Q3 | $3.44M | Buy |
30,304
+1,105
| +4% | +$128K | 0.03% | 440 |
|
|
2017
Q2 | $3.64M | Sell |
29,199
-88,365
| -75% | -$10.5M | 0.03% | 441 |
|
|
2017
Q1 | $13.9M | Sell |
117,564
-32,445
| -22% | -$3.68M | 0.11% | 245 |
|
|
2016
Q4 | $15M | Sell |
150,009
-295,901
| -66% | -$31.7M | 0.12% | 205 |
|
|
2016
Q3 | $56.3M | Buy |
445,910
+28,814
| +7% | +$3.56M | 0.4% | 66 |
|
|
2016
Q2 | $48.7M | Sell |
417,096
-8,629
| -2% | -$977K | 0.34% | 88 |
|
|
2016
Q1 | $44.1M | Buy |
425,725
+67
| +0% | +$6.48K | 0.29% | 107 |
|
|
2015
Q4 | $42.4M | Sell |
425,658
-28,016
| -6% | -$2.74M | 0.27% | 117 |
|
|
2015
Q3 | $41.4M | Sell |
453,674
-446,148
| -50% | -$44.7M | 0.29% | 114 |
|
|
2015
Q2 | $95.4M | Sell |
899,822
-3,348
| -0.4% | -$370K | 0.59% | 35 |
|
|
2015
Q1 | $103M | Buy |
903,170
+65,939
| +8% | +$7.52M | 0.65% | 28 |
|
|
2014
Q4 | $92.2M | Buy |
837,231
+242,975
| +41% | +$25.6M | 0.61% | 39 |
|
|
2014
Q3 | $58M | Sell |
594,256
-20,483
| -3% | -$2.01M | 0.39% | 70 |
|
|
2014
Q2 | $62M | Sell |
614,739
-16,271
| -3% | -$1.59M | 0.39% | 73 |
|
|
2014
Q1 | $57.9M | Buy |
631,010
+623,630
| +8,450% | +$57.5M | 0.37% | 76 |
|
|
2013
Q4 | $668K | Buy |
+7,380
| New | +$639K | ﹤0.01% | 561 |
|
Other funds holding ZBH
VCM
VPM
Calamos Advisors's ZBH Position: Q1 2026 in Review
Calamos Advisors held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 45,478 shares worth $4.11M. The position accounts for 0.01% of the portfolio, ranked #589.
Calamos Advisors first reported a position in ZBH in Q4 2013 and has held it in 50 quarters since. The position peaked at $103M in Q1 2015. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Calamos Advisors held 45,478 shares of Zimmer Biomet worth $4.11M as of Q1 2026.
- Calamos Advisors left its Zimmer Biomet share count unchanged in Q1 2026.
- Zimmer Biomet made up 0.01% of Calamos Advisors's portfolio in Q1 2026, its #589 holding.
- Calamos Advisors first reported a position in Zimmer Biomet in Q4 2013 and has held it in 50 quarters since.
- Calamos Advisors's Zimmer Biomet position peaked at $103M in Q1 2015.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Calamos Advisors's 13F filing for Q1 2026, filed 4 May 2026.